Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.
about
Safety of engineered allergen-specific immunotherapy vaccinesVaccines for allergyRecombinant house dust mite allergens.Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy.Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy.Identification of IgE-binding peptide and critical amino acids of Jatropha curcas allergen involved in allergenic responseAllergen-specific IgG antibodies purified from mite-allergic patients sera block the IgE recognition of Dermatophagoides pteronyssinus antigens: an in vitro study.Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.Regulatory functions of B cells in allergic diseases.Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity.Grass pollen immunotherapy: where are we now.Oral application of lactic acid bacteria following treatment with antibiotics inhibits allergic airway inflammation.Mucosal delivery of allergen peptides expressed by Lactococcus lactis inhibit allergic responses in a BALB/c mouse model.Suppression of dust mite allergy by mucosal delivery of a hypoallergenic derivative in a mouse model.Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.
P2860
Q26860962-9899A786-3517-4DB9-9EE3-7AEA35968E70Q27006550-6064470D-3E45-4B98-895D-DE26410C9A04Q34361546-3AA1FC24-78BD-454B-B759-447DD530C8A5Q34415246-077515C2-29E3-47B2-900F-CC1520DFF4D2Q34430399-CA49EEA1-ADD0-46F4-BEE9-113337C1DE4BQ35791686-55E7C863-6248-45A5-9B9D-721E30148283Q36798819-EDD6BD9A-ED8E-4E71-991C-04F1CEEF733AQ37166041-12FEA4B1-7464-4D3D-8B6A-75AEA6C2A036Q38013789-43554258-5424-4F80-BEC6-31F15CF755FAQ38233691-68155FC8-4A8D-4579-822A-D60B198A811EQ38442377-61C18E47-EA52-4490-B31C-54CF05E1AC92Q38773340-32E6AA18-18F7-4D49-8B7F-A38B8B7888E3Q41135569-5C200594-81B2-4794-B6BF-48E32509C8C3Q50906879-2E6D2383-1D7D-49DD-A6EE-229B495246B9Q51010282-334FC529-A489-47D5-8A7E-9F2BE51A5FD9Q55436442-ADD736DB-CC28-458B-BB8B-3CF1877EDF3F
P2860
Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Carrier-bound nonallergenic De ...... tivation in allergic patients.
@ast
Carrier-bound nonallergenic De ...... tivation in allergic patients.
@en
type
label
Carrier-bound nonallergenic De ...... tivation in allergic patients.
@ast
Carrier-bound nonallergenic De ...... tivation in allergic patients.
@en
prefLabel
Carrier-bound nonallergenic De ...... tivation in allergic patients.
@ast
Carrier-bound nonallergenic De ...... tivation in allergic patients.
@en
P2093
P2860
P50
P1433
P1476
Carrier-bound nonallergenic De ...... ctivation in allergic patients
@en
P2093
F Dall'Antonia
M Focke-Tejkl
M Kneidinger
P2860
P304
P356
10.1111/J.1398-9995.2012.02794.X
P577
2012-02-17T00:00:00Z